Renal prostaglandins: relationship to the development of blood pressure and concentrating capacity in pre-term and full term healthy infants.
The relationships between urinary prostaglandins (PGs)E2 and F2 alpha and the postnatal development of blood pressure and renal concentrating capacity were investigated in 14 pre-term and 32 full term healthy infants. Mean PGE2 and PGF2 alpha excretion was 18.9 and 10.1 ng/h/1.73 m2, respectively, in pre-term infant. In full term infants mean urinary PGE2 was significantly lower (13.4 ng/h/1.73 m2) and PGF2 alpha significantly higher (22.2 ng/h/1.73 m2). The decrease of the PGE2/PGF2 alpha ratio (P less than 0.001) was accompanied by an increase in blood pressure. High PGE2 levels in pre-term infants were inversely correlated with urinary cAMP excretion. A decreasing PGE2/PGF2 alpha ratio in full term infants was associated with increasing urinary osmolality. After intranasal administration of antidiuretic hormone (DDAVP) in 8 full term infants the increase in urinary osmolality and cAMP excretion was accompanied by a drop in PGE2 excretion to less than half the basal values. These findings suggests that the postnatal changes in urinary PG excretion are associated with a concomittant increase in blood pressure and in the concentrating capacity of the neonatal kidney.
D001794:Blood Pressure; D000242:Cyclic AMP / Q000652:urine; D003894:Deamino Arginine Vasopressin / Q000494:pharmacology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007234:Infant, Premature; D007671:Kidney Concentrating Ability; D011458:Prostaglandins E / Q000652:urine*; D011460:Prostaglandins F / Q000652:urine*
D011458:Prostaglandins E; D011460:Prostaglandins F; D000242:Cyclic AMP; D003894:Deamino Arginine Vasopressin